The cases could overturn a legal principle known as the "Chevron doctrine" under which courts have typically deferred to ...

In one case, the owners of an independent laboratory have been charged in a $36 million COVID-19 testing fraud scheme.

Among the charges against the owners of Innovative Genomics are allegations that they submitted healthcare benefit claims for unnecessary and non-reimbursable COVID-19 testing.

The money, which includes an equity investment, will be used to advance the company's breath-based diagnostic technology for respiratory disease.

The firm's revenues for Q1 were $3.18 billion, up from $3.04 billion in the same quarter last year and above the consensus Wall Street estimate of $3.12 billion.

With a leaner team and budget, the program aims to accelerate novel diagnostics that fill unmet needs while also propagating its model throughout other NIH divisions.

NEW YORK – RTI International and Revvity said on Thursday that starting next month, Revvity will conduct genome sequencing for RTI's Early Check newborn screening study in North Carolina. The deal, ...

NEW YORK – ALPCO-GeneProof said on Thursday it is partnering with Revvity subsidiary Euroimmun for the distribution of dozens of GeneProof PCR kits throughout the European Union. The firms said that ...